Cargando…
Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case
OBJECTIVE: Many treatment decisions are preference-sensitive and call for shared decision-making, notably when benefits are limited or uncertain, and harms impact quality of life. We explored if clinical practice guidelines (CPGs) acknowledge preference-sensitive decisions in how they motivate and p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924854/ https://www.ncbi.nlm.nih.gov/pubmed/31811009 http://dx.doi.org/10.1136/bmjopen-2019-032483 |
_version_ | 1783481804849676288 |
---|---|
author | Gärtner, Fania R Portielje, Johanneke E Langendam, Miranda Hairwassers, Desiree Agoritsas, Thomas Gijsen, Brigitte Liefers, Gerrit-Jan Pieterse, Arwen H Stiggelbout, Anne M |
author_facet | Gärtner, Fania R Portielje, Johanneke E Langendam, Miranda Hairwassers, Desiree Agoritsas, Thomas Gijsen, Brigitte Liefers, Gerrit-Jan Pieterse, Arwen H Stiggelbout, Anne M |
author_sort | Gärtner, Fania R |
collection | PubMed |
description | OBJECTIVE: Many treatment decisions are preference-sensitive and call for shared decision-making, notably when benefits are limited or uncertain, and harms impact quality of life. We explored if clinical practice guidelines (CPGs) acknowledge preference-sensitive decisions in how they motivate and phrase their recommendations. DESIGN: We performed a qualitative analysis of the content of CPGs and verified the results in semistructured interviews with CPG panel members. SETTING: Dutch oncology CPGs issued in 2010 or later, concerning primary treatment with curative intent. PARTICIPANTS: 14 CPG panel members. MAIN OUTCOMES: For treatment recommendations from six CPG modules, two researchers extracted the following: strength of recommendation in terms of the Grading of Recommendations Assessment, Development and Evaluation and its consistency with the CPG text; completeness of presentation of benefits and harms; incorporation of patient preferences; statements on the panel’s benefits–harm trade-off underlying recommendation; and advice on patient involvement in decision-making. RESULTS: We identified 32 recommendations, 18 were acknowledged preference-sensitive decisions. Three of 14 strong recommendations should have been weak based on the module text. The reporting of benefits and harms, and their probabilities, was sufficiently complete and clear to inform the strength of the recommendation in one of the six modules only. Numerical probabilities were seldom presented. None of the modules presented information on patient preferences. CPG panel’s preferences were not made explicit, but appeared to have impacted 15 of 32 recommendations. Advice to involve patients and their preferences in decision-making was given for 20 recommendations (14 weak). Interviewees confirmed these findings. Explanations for lack of information were, for example, that clinicians know the information and that CPGs must be short. Explanations for trade-offs made were cultural-historical preferences, compliance with daily care, presumed role of CPGs and lack of time. CONCLUSIONS: The motivation and phrasing of CPG recommendations do not stimulate choice awareness and a neutral presentation of options, thus hindering shared decision-making. |
format | Online Article Text |
id | pubmed-6924854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-69248542020-01-03 Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case Gärtner, Fania R Portielje, Johanneke E Langendam, Miranda Hairwassers, Desiree Agoritsas, Thomas Gijsen, Brigitte Liefers, Gerrit-Jan Pieterse, Arwen H Stiggelbout, Anne M BMJ Open Health Services Research OBJECTIVE: Many treatment decisions are preference-sensitive and call for shared decision-making, notably when benefits are limited or uncertain, and harms impact quality of life. We explored if clinical practice guidelines (CPGs) acknowledge preference-sensitive decisions in how they motivate and phrase their recommendations. DESIGN: We performed a qualitative analysis of the content of CPGs and verified the results in semistructured interviews with CPG panel members. SETTING: Dutch oncology CPGs issued in 2010 or later, concerning primary treatment with curative intent. PARTICIPANTS: 14 CPG panel members. MAIN OUTCOMES: For treatment recommendations from six CPG modules, two researchers extracted the following: strength of recommendation in terms of the Grading of Recommendations Assessment, Development and Evaluation and its consistency with the CPG text; completeness of presentation of benefits and harms; incorporation of patient preferences; statements on the panel’s benefits–harm trade-off underlying recommendation; and advice on patient involvement in decision-making. RESULTS: We identified 32 recommendations, 18 were acknowledged preference-sensitive decisions. Three of 14 strong recommendations should have been weak based on the module text. The reporting of benefits and harms, and their probabilities, was sufficiently complete and clear to inform the strength of the recommendation in one of the six modules only. Numerical probabilities were seldom presented. None of the modules presented information on patient preferences. CPG panel’s preferences were not made explicit, but appeared to have impacted 15 of 32 recommendations. Advice to involve patients and their preferences in decision-making was given for 20 recommendations (14 weak). Interviewees confirmed these findings. Explanations for lack of information were, for example, that clinicians know the information and that CPGs must be short. Explanations for trade-offs made were cultural-historical preferences, compliance with daily care, presumed role of CPGs and lack of time. CONCLUSIONS: The motivation and phrasing of CPG recommendations do not stimulate choice awareness and a neutral presentation of options, thus hindering shared decision-making. BMJ Publishing Group 2019-12-05 /pmc/articles/PMC6924854/ /pubmed/31811009 http://dx.doi.org/10.1136/bmjopen-2019-032483 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Health Services Research Gärtner, Fania R Portielje, Johanneke E Langendam, Miranda Hairwassers, Desiree Agoritsas, Thomas Gijsen, Brigitte Liefers, Gerrit-Jan Pieterse, Arwen H Stiggelbout, Anne M Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case |
title | Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case |
title_full | Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case |
title_fullStr | Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case |
title_full_unstemmed | Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case |
title_short | Role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case |
title_sort | role of patient preferences in clinical practice guidelines: a multiple methods study using guidelines from oncology as a case |
topic | Health Services Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924854/ https://www.ncbi.nlm.nih.gov/pubmed/31811009 http://dx.doi.org/10.1136/bmjopen-2019-032483 |
work_keys_str_mv | AT gartnerfaniar roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT portieljejohannekee roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT langendammiranda roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT hairwassersdesiree roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT agoritsasthomas roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT gijsenbrigitte roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT liefersgerritjan roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT pietersearwenh roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase AT stiggelboutannem roleofpatientpreferencesinclinicalpracticeguidelinesamultiplemethodsstudyusingguidelinesfromoncologyasacase |